Publikationen Prof. Dr. med. Peter J. Wild

2018

Seoane M, Buhs S, Iglesias P, Strauss J, Puller AC, Müller J, Gerull H, Feldhaus S, Alawi M, Brandner JM, Eggert D, Du J, Thomale J, Wild PJ, Zimmermann M, Sternsdorf T, Schumacher U, Nollau P, Fisher DE, Horstmann MA (2018) Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair. Oncogene.

IF 6.854

 

Keller EX, Bachofner J, Britschgi AJ, Saba K, Mortezavi A, Kaufmann B, Fankhauser CD, Wild P, Sulser T, Hermanns T, Eberli D, Poyet C (2018) Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer. World J. Urol.

IF 2.981

 

Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U (2018) DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. J. Clin. Invest. 129:223-229.

IF 13.250

 

Leão R, Lee D, Figueiredo A, Hermanns T, Wild P, Komosa M, Lau I, Mistry M, Nunes NM, Price AJ, Zhang C, Lipman T, Poyet C, Valtcheva N, Oehl K, Coelho H, Sayyid R, Gomes AM, Prado E Castro L, Sweet J, Vinagre J, Apolónio J, Stephens D, Faleiro I, Fadaak K, Richard PO, Kulkarni G, Zlotta AR, Hamilton RJ, Castelo-Branco P, Tabori U (2018) Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer. Int. J. Cancer. 144:1676-1684.

IF 5.444

 

Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A (2018) Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort. J. Thorac. Oncol. 13:1851-1863.

IF 10.336

 

Arvaniti E, Fricker K S, Moret M, Rupp N, Hermanns T, Fankhauser C, Wey N, Wild P J, Rüschoff J H, Claassen M (2018) Automated Gleason grading of prostate cancer tissue microarrays via deep learning. Sci Rep. 8:12054.

IF 4.259

 

Guo T, Li L, Zhong Q, Rupp N J, Charmpi K, Wong C E, Wagner U, Rueschoff J H, Jochum W, Fankhauser C D, Saba K, Poyet C, Wild P J, Aebersold R, Beyer A (2018) Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers. Life Sci Alliance 1: e201800042.

 

Zhong Q, Wagner U, Kurt H, Molinari F, Cathomas G, Komminoth P, Barman-Aksözen J, Schneider-Yin X, Rey JP, Vassella E, Rogel U, Diebold J, McKee T, Jochum W, Kashofer K, Hofman P, Zischka M, Moch H, Rechsteiner M, Wild P J (2018) Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing. Pathol. Res. Pract. 214:957-963.

IF 2.994

 

Brandt L P, Albers J, Hejhal T, Pfundstein S, Gonçalves A F, Catalano A, Wild P J, Frew I J (2018) Mouse genetic background influences whether HrasG12V expression plus Cdkn2a knockdown causes angiosarcoma or undifferentiated pleomorphic sarcoma. Oncotarget. 9:19753-19766.

IF 5.168

 

Velizheva N P, Rechsteiner M P, Valtcheva N, Freiberger S N, Wong C E, Vrugt B, Zhong Q, Wagner U, Moch H, Hillinger S, Schmitt-Opitz I, Soltermann A, Wild P J, Tischler V (2018) Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study. Pathol. Res. Pract. 214:572-578.

IF 2.994

 

Rechsteiner M, Dedes K, Fink D, Pestalozzi B, Sobottka B, Moch H, Wild P, Varga Z (2018) Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. J Cancer Res Clin Oncol. 144:865-874.

IF 3.503

 

Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S (2018) p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urol Oncol. 36:94.

IF 0.818

 

Oehl K, Kresoja-Rakic J, Opitz I, Vrugt B, Weder W, Stahel R, Wild P, Felley-Bosco E (2018) Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression. Front. Oncol. 8:40.

 

Erichsen L, Ghanjati F, Beermann A, Poyet C, Hermanns T, Schulz WA, Seifert H H, Wild P J, Buser L, Kröning A, Braunstein S, Anlauf M, Jankowiak S, Hassan M, Bendhack M L, Bravo M A, Santourlidis S (2018) Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Sci Rep. 8:3477.

IF 4.259

 

2017

Fankhauser C D, Schüffler P J, Gillessen S, Omlin A, Rupp N J, Rueschoff J H, Hermanns T, Poyet C, Sulser T, Moch H, Wild P J (2017) Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer. Oncotarget. 9:10284-10293.

IF 5.168

 

Gonçalves AF, Adlesic M, Brandt S, Hejhal T, Harlander S, Sommer L, Shakhova O, Wild P J, Frew I J (2017) Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells. Nat. Commun. 8:1466.

IF 12.124

 

Brandt LP, Albers J, Hejhal T, Catalano A, Wild P J, Frew IJ (2017) Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma. PLoS One. 12(10): e0186102.

IF 2.806

 

Singer J, Ruscheweyh H J, Hofmann AL, Thurnherr T, Singer F, Toussaint NC, Ng C K Y, Piscuoglio S, Beisel C, Christofori G, Dummer R, Hall M N, Krek W, Levesque M, Manz M G, Moch H, Papassotiropoulos A, Stekhoven DJ, Wild P, Wüst T, Rinn B, Beerenwinkel N (2017) NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis. Bioinformatics (accepted).

IF 7.307

 

Nørgaard M, Haldrup C, Storebjerg T M, Vestergaard E M, Wild P J, Høyer S, Borre M, Ørntoft T F, Sørensen K D (2017) Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis. Int J Mol Sci. 18(9).

IF 3.226

 

Shved N, Warsow G, Eichinger F, Hoogewijs D, Brandt S, Wild P, Kretzler M, Cohen CD, Lindenmeyer MT (2017) Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts. Sci. Rep. 7:8576.

IF 4.259

 

Dai X, Gan W, Li X, Zhang W, Liu S, Zhong Q, Guo J, Zhang J, Chen T, Shimizu K, Beca F, Blattner M, Vasudevan D, Buckley D L, Buser L, Liu P, Inuzuka H, Beck A H, Wild P J, Theurillat J P, Garraway L A, Rubin M A, Barbieri C E, Wong K K, Huang J, Bradner J E, Wei W (2017) Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nat. Medicine 23:1063-71.

IF 29.886

 

Janouskova H, El Tekle G, Bellini E, Udeshi N D, Rinaldi A, Ulbricht A, Bernasocchi T, Civenni G, Losa M, Svinkina T, Bielski C M, Kryukov G V, Cascione L,  Enchev R I,  Mutch D G, Carney M E, Berchuck A, Winterhoff B J N, Broaddus R R, Schraml S, Moch H, Dai X, Gan W, Wei W, Bertoni F, Catapano, Peter M, Carr S A, Garraway L A, Wild P J, Theurillat J P (2017) Cancer Type-Specific SPOP Mutants Alter BET Protein Levels and Inhibitor Responses. Nat. Medicine. 23:1046-105.

IF 29.886

&n